News and Announcements
Actinogens’ Xanamem™ to Showcase Cortisol Hypothesis
- Published June 30, 2016 10:08AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
29th Sydney 2016, ASX Announcement
Actinogen Medical (ASX:ACW) is pleased to announce the key data supporting its novel Alzheimer’s drug Xanamem™, has been selected by an independent expert panel for presentation at the world’s largest dementia research conference – the Alzheimer’s Association International conference (AAIC), in Toronto 22nd – 28th July, 2016.
The presentation entitled, “Xanamem™ a novel 188-HSD1 inhibitor with as potential to provide durable symptomatic and disease modifying benefits in Alzheimer’s disease“, will include results on Xanamem™’s succesful Phase I human trials and importantly confirm that following oral administration Xanamem™’s effectively crosses the blood-brain-barrier and gets to the brain, its primary site of action in Alzheimer’s disease.
To view the full announcement, please click on the button below.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
